Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1996 to 2010 of 7682 results

  1. Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]

    Awaiting development [GID-TA10895] Expected publication date: TBC

  2. Somapacitan for treating growth hormone deficiency in children [ID6178]

    In development [GID-TA11153] Expected publication date: TBC

  3. Suspected sepsis: recognition, diagnosis and early management

    In development [GID-NG10412] Expected publication date: 13 August 2025

  4. Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer ID 6436

    Awaiting development [GID-TA11532] Expected publication date: TBC

  5. Datopotamab deruxtecan for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer [ID6435]

    Awaiting development [GID-TA11535] Expected publication date: TBC

  6. Cor-Knot for tying suture knots in valve surgery

      Status ...

  7. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation

      Status ...

  8. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

      Status ...

  9. Upadacitinib for treating giant cell arteritis [ID6299]

    Awaiting development [GID-TA11330] Expected publication date: TBC

  10. Actim Pancreatitis for diagnosing acute pancreatitis

      Status ...

  11. CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic

      Status ...

  12. PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms

      Status ...

  13. Spartan RX point-of-care CYP2C19 test

      Status ...

  14. Healthy.io test for home testing of urine albumin to creatinine ratio

      Status ...

  15. FebriDx for C-reactive protein and myxovirus resistance protein A testing

      Status ...